Erythropoietic recovery during treatment with darbepoietin-alpha after impaired rHuEPO response to anemia in two patients with osteomyelofibrosis after peripheral blood stem cell transplantation.
Nguyen
Van Anh Tran
VA
Fauser
Axel A
AA
Basara
Nadezda
N
Kiehl
Michael
M
D000328:Adult; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy* / Q000209:etiology; D011087:Polycythemia Vera / Q000628:therapy*; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D017211:Treatment Failure; D016896:Treatment Outcome
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa